Elizabeth Williams

Elizabeth Williams is an experienced regulatory affairs professional currently serving as the Executive Director of Regulatory Affairs at Apogee Therapeutics since February 2024. In this role, Elizabeth leads the development and implementation of global regulatory strategies within the Respiratory therapeutic area. Prior to Apogee, Elizabeth held the position of Senior Director of Regulatory Affairs at ACELYRIN, INC., where responsibilities included overseeing global regulatory strategies in dermatology, rheumatology, and ophthalmology. With a substantial tenure at Amgen from 2005 to 2022, Elizabeth advanced through various roles, including Director of Global Regulatory Affairs and Director of International Regulatory Affairs, managing regulatory teams and strategies across multiple therapeutic areas and global regions. Elizabeth's academic qualifications include a Master of Science in Regulatory Science from the University of Southern California and a Bachelor of Science in Natural Sciences from Loyola Marymount University.